Page 28 - FIMM_Brochure_2022
P. 28
SImocpiaectat l
While third mission activities are becoming 3. Delivery of medical imaging and AI-based analysis will
more and more important for universities,
societal impact objectives and knowledge provide new tools for digital pathology that can be used
transfer have always been a key part of locally and globally.
FIMM’s activities.
4. Accurate genome prediction and epidemiologic insights
All of the FIMM Grand Challenge research areas are directly
focused on public health impact, so we consider societal will advise improved clinical guidelines and practices for
impact a direct goal, rather than indirect benefit, of all public health recommendations.
FIMM research. Impact that delivers improvements to the
quality, safety and efficiency of healthcare takes many dif- At the receiving end of the impact of FIMM research are
ferent forms, with major target areas including: our direct clinical colleagues and patients in Helsinki, the
Finnish government and population at large and, in some
1. Predictors of disease and therapeutic response based cases, public health globally.
on individual genome and health history will deliver FIMM researchers have been actively involved, participat-
new, accurate genomic-based diagnostics to the Finnish ing in hearings and providing statements, in the prepa-
healthcare system. ration of national policies and legislation on utilising
genome data and biobanking and the secondary usage
2. Individual cancer patient diagnostics and therapeutic of health data. In addition, we also contribute to science
policies on the European level through the EU-LIFE net-
recommendations will help cancer patients receive work. Furthermore, we are committed to promoting open
more effective treatments. sharing of data as well as Gender Equality, Diversity and
Inclusion in science.
28 | FIMM – Building a Bridge from Discovery to Medicine
